Subgroup analysis on the correlation of SMARCA1 expression and prognosis of liver cancer cases.</p
<p>Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nucle...
<p>Results of subgroup analysis of pooled hazard ratios of overall survival of different types of ca...
<p>Subgroup analyses for association between VEGF-C expression and survival in BC patients.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of gastric cancer cases.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of breast cancer cases.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of lung cancer cases.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of ovarian cancer cases.</p
A series of subgroups survival analyses in breast, ovarian, lung, gastric and liver cancer were cond...
(A) OS, PPS, RFS, DMFS in breast cancer; (B) OS, PFS, PPS in ovarian cancer; (C) OS, FP, PPS in lung...
(A) Overall survival (OS) analyses between SMARCA1 expression and all cancers included; (B) disease-...
<p>Subgroup analysis (by various endpoints) of the studies using CEA/CK20 as the target genes for MA...
(A) Heatmap of correlation between SMARCA1 and the tumor-related immune infiltration level of cancer...
<p>Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nucle...
(A) Analysis of SMARCA1 gene expression in different tissues by the consensus datasets of HPA, GTEx ...
The reported pathogenic pathways mediated by SMARCA1 in different disorders and cancers are displaye...
<p>Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nucle...
<p>Results of subgroup analysis of pooled hazard ratios of overall survival of different types of ca...
<p>Subgroup analyses for association between VEGF-C expression and survival in BC patients.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of gastric cancer cases.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of breast cancer cases.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of lung cancer cases.</p
Subgroup analysis on the correlation of SMARCA1 expression and prognosis of ovarian cancer cases.</p
A series of subgroups survival analyses in breast, ovarian, lung, gastric and liver cancer were cond...
(A) OS, PPS, RFS, DMFS in breast cancer; (B) OS, PFS, PPS in ovarian cancer; (C) OS, FP, PPS in lung...
(A) Overall survival (OS) analyses between SMARCA1 expression and all cancers included; (B) disease-...
<p>Subgroup analysis (by various endpoints) of the studies using CEA/CK20 as the target genes for MA...
(A) Heatmap of correlation between SMARCA1 and the tumor-related immune infiltration level of cancer...
<p>Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nucle...
(A) Analysis of SMARCA1 gene expression in different tissues by the consensus datasets of HPA, GTEx ...
The reported pathogenic pathways mediated by SMARCA1 in different disorders and cancers are displaye...
<p>Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nucle...
<p>Results of subgroup analysis of pooled hazard ratios of overall survival of different types of ca...
<p>Subgroup analyses for association between VEGF-C expression and survival in BC patients.</p
DOI
Add to ORKG